Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  09 AM Call for Abstracts
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 37, 2838-2842, August 1, 1977]
© 1977 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Skinner, D. G.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Skinner, D. G.

Current State of Classification and Staging of Bladder Cancer1

Donald G. Skinner

Division of Urology, UCLA School of Medicine, Los Angeles, California 90024

The most important determinant for treatment as well as prognosis is the presence or absence of muscle invasion as determined by the histopathological material obtained by a properly performed biopsy. Histological grade of the tumor is also important inasmuch as high-grade tumors are usually always associated with invasion, whereas low-grade tumors are usually superficial. The presence or absence of carcinoma in situ is also an important histological feature and may be diagnosed with increasing accuracy by improved cytopathological techniques.

The TNM system, although useful in the accurate staging of definitive cystectomy specimens, offers little to clinical management. The inherent and significant problems of clinical staging and difficulties in attempting to correlate presenting pathology with correct management planning persist. What is needed, in my opinion, is simplification of clinical staging, elimination of stages that cannot be accurately determined by existing methods, and better identification of criteria for treatment planning.

1 Presented at the National Bladder Cancer Conference, November 28 to December 1, 1976, Miami Beach, Fla.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1977 by the American Association for Cancer Research.